Showing 701-710 of 806 results for "".
The Microbiome in Acne: Where are We Now?
https://practicaldermatology.com/topics/acne-rosacea/the-microbiome-in-acne-where-are-we-now/23731/As research reveals connections of the microbiome to skin disease, clinicians may discover new approaches to managing the disease.Topical Treatment Options for Hyperhidrosis
https://practicaldermatology.com/youngmd-connect/resident-resource-center/topical-treatment-options-for-hyperhidrosis/23340/A review of topical therapies for primary focal hyperhidrosisReduce Your Life Insurance Costs
https://practicaldermatology.com/topics/practice-management/reduce-your-life-insurance-costs/20630/You “refi” your mortgage when rates go down. Here are seven reasons to do the same for your life insurance.AI and Skin of Color: Hidden Biases Raise Questions
https://practicaldermatology.com/topics/skin-of-color/ai-and-skin-of-color-hidden-biases-raise-questions/23994/AI holds potential for practitioners, but it’s important to think critically about what data we use to build models.The Future of Treatment and Research for Giant Congenital Melanocytic Nevi
https://practicaldermatology.com/topics/skin-cancer-photoprotection/the-future-of-treatment-and-research-for-giant-congenital-melanocytic-nevi/57252/Congenital melanocytic nevi (CMN) have long posed a clinical paradox: lesions that are often benign in behavior yet burdened by a measurable risk of melanoma and significant psychosocial impact. Present at birth or emerging in early infancy, CMN vary widely in size, distribution, and long-term impliRecent Advances in Hair Restoration
https://practicaldermatology.com/topics/hair-nails/recent-advances-in-hair-restoration/23233/Noted hair loss expert Jerry Shapiro, MD delivered an overview on treating hair loss conditions and an update on evolving trends in the field at Maui Derm.What Does Efficacy Cost? Evidence for Relative Cost-Effectiveness of Biologic Therapies for Psoriasis
https://practicaldermatology.com/topics/psoriasis/what-does-efficacy-cost-evidence-for-relative-cost-effectiveness-of-biologic-therapies-for-psoriasis/23128/Despite high costs, evidence suggests that biologics are cost-effective options for moderate to severe psoriasis because of their efficacy.The Millennials are Coming
https://practicaldermatology.com/topics/practice-management/the-millennials-are-coming/21131/The new generation learns, interacts, and is inspired differently than a generation ago, and to stay relevant it is necessary to adapt.Tips for Management of Cutaneous Squamous Cell Carcinoma
https://practicaldermatology.com/topics/skin-cancer-photoprotection/tips-for-management-of-cutaneous-squamous-cell-carcinoma/57254/Cutaneous squamous cell carcinoma (cSCC) is one of the most common malignancies encountered in dermatologic practice. Current treatment guidelines for cSCC provide recommendations based largely on tumor risk classification, while emphasizing the importance of clinical judgment and patient-specific fBody Dysmorphic Disorder Screening Tools for the Dermatologist: A Systematic Review
https://practicaldermatology.com/topics/general-topics/body-dysmorphic-disorder-screening-tools-for-the-dermatologist-a-systematic-review-s/21231/